PFIZ34:BVMF
Pfizer BDR
R$34.11
0.00%
(0.00) 1D
Oct 6, 5:05:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFIZ34...
Open
R$34.00
High
R$34.42
Low
R$33.90
Mkt. cap
158.97B
Avg. vol.
8.25K
Volume
0.00
52-wk high
R$37.70
52-wk low
R$30.09
Shares outstanding
5.70B
No. of employees
75K
Open
R$34.00
High
R$34.42
Low
R$33.90
Mkt. cap
158.97B
Avg. vol.
8.25K
Volume
0.00
52-wk high
R$37.70
52-wk low
R$30.09
Shares outstanding
5.70B
No. of employees
75K
News stories
From web sources and news partners
AD HOC NEWS
·
2 hours ago
Pfizer stock pre-market at EUR 24.51: plus 0.41 percent
Insider Monkey
·
12 hours ago
Is Pfizer (PFE) a Good or Bad Investment at Today’s Price?
TradingView
·
17 hours ago
Pfizer Declares Q4 Dividend Of $0.43 Per Share
24/7 Wall St.
·
18 hours ago
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna and Pfizer Inch Higher
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer BDR
CEOAlbert Bourla
Employees75K
Founded1849
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitepfizer.com